دورية أكاديمية
أعرض في EDS

Protocol for cost-effectiveness analysis of a randomised trial of mHealth coaching (Bump2Baby and Me) compared with usual care for healthy gestational weight gain and postnatal outcomes in at-risk women and their offspring in the UK, Australia, Ireland and Spain.

التفاصيل البيبلوغرافية
العنوان: Protocol for cost-effectiveness analysis of a randomised trial of mHealth coaching (Bump2Baby and Me) compared with usual care for healthy gestational weight gain and postnatal outcomes in at-risk women and their offspring in the UK, Australia, Ireland and Spain.
المؤلفون: Nørmark LP; Department of Public Health, University of Copenhagen Faculty of Health and Medical Sciences, Kobenhavn, Denmark laura.pirhonen@sund.ku.dk., McAuliffe F; UCD Perinatal Research Centre, University College Dublin, Dublin, Ireland.; Obstetrics and Gynaecology, National Maternity Hospital, Dublin, Ireland., Maindal HT; Aarhus University, Aarhus, UK., O'Reilly S; Institute of Food and Health, University College Dublin, Dublin, Ireland., Davies A; Centre for Academic Child Health, University of Bristol, Bristol, UK., Burden C; University of Bristol Faculty of Health Sciences, Bristol, UK., Skinner TC; Rural Health School, La Trobe University, Bendigo, Victoria, Australia., Vrangbæk K; Department of Public Health, University of Copenhagen Faculty of Health and Medical Sciences, Kobenhavn, Denmark., Callander E; School of Public Health, University of Technology Sydney, Sydney, UK.
المصدر: BMJ open [BMJ Open] 2024 May 21; Vol. 14 (5), pp. e080823. Date of Electronic Publication: 2024 May 21.
نوع المنشور: Journal Article; Clinical Trial Protocol
اللغة: English
بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE
أسماء مطبوعة: Original Publication: [London] : BMJ Publishing Group Ltd, 2011-
مواضيع طبية MeSH: Diabetes, Gestational*/prevention & control , Diabetes, Gestational*/economics , Gestational Weight Gain* , Telemedicine*/economics, Female ; Humans ; Infant, Newborn ; Pregnancy ; Australia ; Cost-Effectiveness Analysis ; Ireland ; Mentoring/methods ; Mentoring/economics ; Quality-Adjusted Life Years ; Randomized Controlled Trials as Topic ; Spain ; United Kingdom
مستخلص: Introduction: Gestational diabetes mellitus and overweight are associated with an increased likelihood of complications during birth and for the newborn baby. These complications lead to increased immediate and long-term healthcare costs as well as reduced health and well-being in women and infants. This protocol presents the health economic evaluation to investigate the cost-effectiveness of Bump2Baby and Me (B2B&Me), which is a health coaching intervention delivered via smartphone to women at risk of gestational diabetes.
Methods and Analysis: Using data from the B2B&Me randomised controlled trial, this economic evaluation compares costs and health effects between the intervention and control group as an incremental cost-effectiveness ratio. Direct healthcare costs, costs of pharmaceuticals and intervention costs will be included in the analysis, body weight and quality-adjusted life-years for the mother will serve as the effect outcomes. To investigate the long-term cost-effectiveness of the trial, a Markov model will be employed. Deterministic and probabilistic sensitivity analysis will be employed.
Ethics and Dissemination: The National Maternity Hospital Human Research and Ethics Committee was the primary approval site (EC18.2020) with approvals from University College Dublin HREC-Sciences (LS-E-20-150-OReilly), Junta de Andalucia CEIM/CEI Provincial de Granada (2087-M1-22), Monash Health HREC (RES-20-0000-892A) and National Health Service Health Research Authority and Health and Care Research Wales (HCRW) (21/WA/0022). The results from the analysis will be disseminated in scientific papers, through conference presentations and through different channels for communication within the project.
Trial Registration Number: ACTRN12620001240932.
Competing Interests: Competing interests: None declared.
(© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
References: Am J Manag Care. 2001 Aug;7(8):793-803. (PMID: 11519238)
Lancet Diabetes Endocrinol. 2017 Jun;5(6):423-430. (PMID: 28456416)
Health Econ. 2018 Jan;27(1):7-22. (PMID: 28833869)
Pharmacoeconomics. 2023 Apr;41(4):427-438. (PMID: 36720793)
Trials. 2021 Dec 28;22(1):963. (PMID: 34963483)
Int J Gynaecol Obstet. 2023 Jan;160 Suppl 1:56-67. (PMID: 36635082)
J Reprod Med. 1999 Jan;44(1):33-8. (PMID: 9987737)
PLoS One. 2018 Aug 9;13(8):e0202183. (PMID: 30092099)
Stat Methods Med Res. 1999 Mar;8(1):3-15. (PMID: 10347857)
Front Endocrinol (Lausanne). 2022 Jun 06;13:868094. (PMID: 35733768)
Aust N Z J Obstet Gynaecol. 2011 Dec;51(6):499-504. (PMID: 21951203)
Value Health. 2018 May;21(5):596-604. (PMID: 29753358)
Value Health. 2015 Mar;18(2):161-72. (PMID: 25773551)
Pharmacoeconomics. 2018 Jul;36(7):745-758. (PMID: 29779120)
Clin Obstet Gynecol. 2015 Jun;58(2):355-61. (PMID: 25811123)
Am J Obstet Gynecol. 2014 Dec;211(6):617-22.e1. (PMID: 25173186)
Br Med Bull. 2010;96:5-21. (PMID: 21037243)
Acta Obstet Gynecol Scand. 2023 May;102(5):523-531. (PMID: 36799269)
Health Econ. 1997 Jul-Aug;6(4):327-40. (PMID: 9285227)
Am J Obstet Gynecol. 2017 Mar;216(3):250.e1-250.e14. (PMID: 28041927)
Int J Womens Health. 2013 Dec 10;6:1-10. (PMID: 24376363)
BMJ. 1999 Jul 10;319(7202):120. (PMID: 10398643)
Glob Health Action. 2014 Jul 01;7:23987. (PMID: 24990684)
Obstet Gynecol. 2019 Jul;134(1):180. (PMID: 31241589)
Pharmacoeconomics. 2014 Dec;32(12):1157-70. (PMID: 25069632)
JAMA. 2017 Jun 06;317(21):2207-2225. (PMID: 28586887)
Health Econ. 2000 Oct;9(7):623-30. (PMID: 11103928)
Nutr Metab Cardiovasc Dis. 2021 May 6;31(5):1427-1433. (PMID: 33846005)
Best Pract Res Clin Obstet Gynaecol. 2021 Jan;70:2-9. (PMID: 32773291)
JMIR Res Protoc. 2023 Sep 18;12:e51431. (PMID: 37721798)
BMJ. 2020 May 13;369:m1361. (PMID: 32404325)
Health Econ. 2004 May;13(5):405-15. (PMID: 15127421)
J Hum Nutr Diet. 2022 Apr;35(2):250-264. (PMID: 35239212)
Diabet Med. 2015 Apr;32(4):467-76. (PMID: 25529506)
Pharmacoeconomics. 2018 Aug;36(8):889-901. (PMID: 29679317)
Diabetes Care. 2002 Sep;25(9):1619-24. (PMID: 12196437)
BMC Health Serv Res. 2020 Nov 27;20(1):1098. (PMID: 33246460)
Pharmacoeconomics. 2018 Nov;36(11):1345-1353. (PMID: 30051267)
Pharmacoeconomics. 1998 Apr;13(4):397-409. (PMID: 10178664)
BMJ. 2022 Jan 11;376:e067975. (PMID: 35017145)
فهرسة مساهمة: Keywords: Diabetes in pregnancy; HEALTH ECONOMICS; Randomized Controlled Trial
تواريخ الأحداث: Date Created: 20240521 Date Completed: 20240521 Latest Revision: 20240802
رمز التحديث: 20240803
مُعرف محوري في PubMed: PMC11110546
DOI: 10.1136/bmjopen-2023-080823
PMID: 38772891
قاعدة البيانات: MEDLINE
الوصف
تدمد:2044-6055
DOI:10.1136/bmjopen-2023-080823